SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
ACCIPITER CAPITAL MANAGEMENT, LLC
(Last) (First) (Middle)
666 5TH AVENUE
35TH FLOOR
(Street)
NEW YORK NY 10103
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ORCHID CELLMARK INC [ ORCH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/29/2008
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.001 Par Value 09/30/2008 P 4,763 A $2.8667 798,692 I By ALSF (Offshore), Ltd.(1)
Common Stock, $0.001 Par Value 10/01/2008 J(2) 148,030 A $2.88 946,722 I By ALSF (Offshore), Ltd.(1)
Common Stock, $0.001 Par Value 10/03/2008 P 691 A $2.3827 947,413 I By ALSF (Offshore), Ltd.(1)
Common Stock, $0.001 Par Value 10/03/2008 P 60,765 A $2.3798 1,008,178 I By ALSF (Offshore), Ltd.(1)
Common Stock, $0.001 Par Value 10/01/2008 J(2) 190,098 D $2.88 567,747 I By ALSF II (Offshore), Ltd.(3)
Common Stock, $0.001 Par Value 10/03/2008 P 102 A $2.3827 567,849 I By ALSF II (Offshore), Ltd.(3)
Common Stock, $0.001 Par Value 10/03/2008 P 8,996 A $2.3798 576,845 I By ALSF II (Offshore), Ltd.(3)
Common Stock, $0.001 Par Value 10/01/2008 J(2) 339,731 D $2.88 77,602 I By ALSF II (QP), LP(4)
Common Stock, $0.001 Par Value 10/03/2008 P 2,369 A $2.3827 79,971 I By ALSF II (QP), LP(4)
Common Stock, $0.001 Par Value 10/03/2008 P 208,350 A $2.3798 288,321 I By ALSF II (QP), LP(4)
Common Stock, $0.001 Par Value 10/01/2008 J(2) 238,556 A $2.88 598,229 I By ALSF II, LP(5)
Common Stock, $0.001 Par Value 10/03/2008 P 177 A $2.3827 598,406 I By ALSF II, LP(5)
Common Stock, $0.001 Par Value 10/03/2008 P 15,611 A $2.3798 614,017 I By ALSF II, LP(5)
Common Stock, $0.001 Par Value 09/29/2008 P 44 A $2.6525 770,813 I By ALSF, LP(6)
Common Stock, $0.001 Par Value 09/30/2008 P 4,638 A $2.8667 775,451 I By ALSF, LP(6)
Common Stock, $0.001 Par Value 10/01/2008 J(2) 143,243 A $2.88 918,694 I By ALSF, LP(6)
Common Stock, $0.001 Par Value 10/03/2008 P 661 A $2.3827 919,355 I By ALSF, LP(6)
Common Stock, $0.001 Par Value 10/03/2008 P 58,137 A $2.3798 977,492 I By ALSF, LP(6)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
ACCIPITER CAPITAL MANAGEMENT, LLC
(Last) (First) (Middle)
666 5TH AVENUE
35TH FLOOR
(Street)
NEW YORK NY 10103
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Candens Capital LLC
(Last) (First) (Middle)
666 5TH AVENUE
35TH FLOOR
(Street)
NEW YORK NY 10103
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
HOFFMAN GABE
(Last) (First) (Middle)
666 5TH AVENUE
35TH FLOOR
(Street)
NEW YORK NY 10103
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
ACCIPITER LIFE SCIENCES FUND LP
(Last) (First) (Middle)
666 5TH AVENUE
35TH FLOOR
(Street)
NEW YORK NY 10103
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director 10% Owner
Officer (give title below) X Other (specify below)
See Explanation of Responses
1. Name and Address of Reporting Person*
ACCIPITER LIFE SCIENCES FUND II L P
(Last) (First) (Middle)
666 5TH AVENUE
35TH FLOOR
(Street)
NEW YORK NY 10103
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director 10% Owner
Officer (give title below) X Other (specify below)
See Explanation of Responses
1. Name and Address of Reporting Person*
ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD
(Last) (First) (Middle)
666 5TH AVENUE
35TH FLOOR
(Street)
NEW YORK NY 10103
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director 10% Owner
Officer (give title below) X Other (specify below)
See Explanation of Responses
1. Name and Address of Reporting Person*
Accipiter Life Sciences Fund II Offshore Ltd
(Last) (First) (Middle)
666 5TH AVENUE
35TH FLOOR
(Street)
NEW YORK NY 10103
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director 10% Owner
Officer (give title below) X Other (specify below)
See Explanation of Responses
1. Name and Address of Reporting Person*
ACCIPITER LIFE SCIENCES FUND II QP L P
(Last) (First) (Middle)
666 5TH AVENUE
35TH FLOOR
(Street)
NEW YORK NY 10103
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director 10% Owner
Officer (give title below) X Other (specify below)
See Explanation of Responses
Explanation of Responses:
1. Held by Accipiter Life Sciences Fund (Offshore), Ltd. Accipiter Capital Management, LLC, the investment manager of Accipiter Life Sciences Fund (Offshore), Ltd. and Gabe Hoffman, the managing member of Accipiter Capital Management, LLC, disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein.
2. On October 1, 2008, Accipiter Life Sciences Fund II (Offshore), Ltd. and Accipiter Life Sciences Fund II (QP), LP transferred shares to Accipiter Life Sciences Fund (Offshore), Ltd., Accipiter Life Sciences Fund, LP and Accipiter Life Sciences Fund II, LP. The prices disclosed in the table above reflect the closing price of the Issuer's Common Stock on September 30, 2008.
3. Held by Accipiter Life Sciences Fund II (Offshore), Ltd. Accipiter Capital Management, LLC, the investment manager of Accipiter Life Sciences Fund II (Offshore), Ltd. and Gabe Hoffman, the managing member of Accipiter Capital Management, LLC, disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein.
4. Held by Accipiter Life Sciences Fund II (QP), LP. Candens Capital, LLC, the general partner of Accipiter Life Sciences Fund II (QP), LP and Gabe Hoffman, the managing member of Candens Capital, LLC, disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein.
5. Held by Accipiter Life Sciences Fund II, LP. Candens Capital, LLC, the general partner of Accipiter Life Sciences Fund II, LP and Gabe Hoffman, the managing member of Candens Capital, LLC, disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein.
6. Held by Accipiter Life Sciences Fund, LP. Candens Capital, LLC, the general partner of Accipiter Life Sciences Fund, LP and Gabe Hoffman, the managing member of Candens Capital, LLC, disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein.
Remarks:
By: Accipiter Capital Management, LLC; By: /s/ Gabe Hoffman, Managing Member 10/03/2008
By: Candens Capital, LLC; By: /s/ Gabe Hoffman, Managing Member 10/03/2008
By: /s/ Gabe Hoffman 10/03/2008
By: Accipiter Life Sciences Fund, LP; By: Candens Capital, LLC, its General Partner; By: /s/ Gabe Hoffman, Managing Member 10/03/2008
By: Accipiter Life Sciences Fund II, LP; By: Candens Capital, LLC, its General Partner; By: /s/ Gabe Hoffman, Managing Member 10/03/2008
By: Accipiter Life Sciences Fund (Offshore), Ltd.; By: Accipiter Capital Management, LLC, its Investment Manager; By: /s/ Gabe Hoffman, Managing Member 10/03/2008
By: Accipiter Life Sciences Fund II (Offshore), Ltd.; By: Accipiter Capital Management, LLC, its Investment Manager; By: /s/ Gabe Hoffman, Managing Member 10/03/2008
By: Accipiter Life Sciences Fund II (QP), LP; By: Candens Capital, LLC, its General Partner; By: /s/ Gabe Hoffman, Managing Member 10/03/2008
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.